Cash Flow

v3.24.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities    
Net (loss) income from operations $ (7,912,919) $ (1,568,180)
Adjustments to reconcile net income from continuing operations to net cash provided by operating activities:    
Depreciation and amortization 4,089,722 3,359,050
Accrued interest on note recievable from Bloomios 0 (141,635)
Amortization of senior security original issue discount 0 (455,450)
Unreimburesed transition fees from Bloomios 0 (428,500)
Amortization of loan costs 50,459 0
Amortization of consideration discount 900,339 0
Non-cash consideration for sale of Infusionz and select assets, net 0 (7,564,363)
Inventory write-offs 1,812,319 34,328
Gain on sale of interactive offers (237,670) 0
Change in deferred tax asset (2,668,993) (515,089)
Noncontrolling interest 0 (358,390)
Shares issued for finder fee 0 1,770
Stock based compensation 965,229 3,126,472
Changes in assets and liabilities, net of acquired amounts    
Accounts receivable 2,413,987 2,175,850
Inventory (255,500) 2,561,502
Prepaid expenses and other assets 492,343 94,178
Operating lease payable 301,492 (22,830)
Accounts payable and accrued liabilities (2,775,503) 1,744,961
Deferred revenue (22,431) 0
Net cash provided by operating activities - Continuing Operations (2,847,126) 2,043,674
Net cash provided by (used in) operating activities - Discontinued Operations (187,280) 190,539
Net cash provided by operating activities (3,034,406) 2,234,213
Cash flows from investing activities    
Acquisition of Lucky Tail 0 (3,012,327)
Acquisition of VitaMedica, Inc., net of cash acquired 0 (500,000)
Acquisition of New England Technology, Inc. 0 (1,698,748)
Proceeds from the sale of Interactive Offers, net of liabilities paid 940,000 0
Acquisition of patent rights for Tytan Tiles (70,000) 0
Acquisition of Cygnet Online LLC, net of cash acquired (500,000) (1,050,000)
Proceeds from the sale of Infusionz and selected assets 0 5,173,610
Acquisition of property and equipment (770,721) (278,683)
Net cash provided by (used in) investing activities - Continuing Operations (400,721) (1,366,148)
Net cash (used in) provided by investing activities - Discontinued Operations 0 0
Net cash provided by (used in) investing activities (400,721) (1,366,148)
Cash flows from financing activities    
Repayment of notes payable (430,715) (470,168)
Repayment of the senior convertible notes payable 0 (6,307,775)
Proceeds (payments) on line of credit, net 3,055,927 (6,826,338)
Payment on acquisition notes payable (3,184,089)  
Repayment of SBA note payable   (254,804)
Proceeds from convertible note payable 0 2,650,000
Proceeds on note payable on building 0 3,000,000
Repayment on note payable on building   (97,744)
Proceeds on note payable, related party 0 1,470,000
Net cash used in financing activities - Continuing Operations (558,877) (6,836,829)
Net cash (used in) provided by financing activities - Discontinued Operations 0 0
Net cash used in financing activities (558,877) (6,836,829)
Net decrease in cash - Continuing Operations (3,806,724) (6,159,303)
Net (decrease) increase in cash - Discontinued Operations (187,280) 190,539
Cash, beginning of period 4,492,291 7,149,806
Cash, end of period 498,287 1,181,042
Supplemental cash flow disclosures    
Interest paid 1,505,162 326,918
Income tax paid 0 0
Issuance of common stock for acquisition of Cygnet 162,727 0
Issuance of debt for acquisition of Cygnet 300,000 0
Bloomios non-cash payment of receivables, net 845,443 0
Issuance of common stock for the repayment of convertible note payable 500,000 0
Liabilities assumed from acquisition of E-Core 0 (7,712,168)
Issuance of stock for acquisition of E-Core 0 6,000,000
Assets available for sale $ 0 $ 6,446,210

Source

PDF HTML
ZIP